Playback speed
10 seconds
2021 WCLC Durvalumab ± Tremelimumab + Chemo as 1L Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
91 views
October 26, 2021
Login to view comments.
Click here to Login